Literature DB >> 17938213

Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice.

Jean-François Marquis1, André Nantel, Ronald LaCourse, Lynn Ryan, Robert J North, Philippe Gros.   

Abstract

The differential susceptibility of inbred mouse strains DBA/2J (susceptible) and C57BL/6J (resistant) to pulmonary tuberculosis following aerosol infection is under complex genetic control. In this report, transcriptional profiling with RNAs from Mycobacterium tuberculosis-infected lungs was used to investigate the physiological response, cell type, and biochemical pathways underlying differential susceptibility to infection. Statistical analysis of cDNA-based microarrays revealed that 1,097 transcripts showed statistically significant changes in abundance (changes of > or = 1.5-fold) in at least one of four experimental group comparisons (C57BL/6J [day 0] versus DBA/2J [day 0] mice, C57BL/6J [day 90] versus DBA/2J [day 90] mice, C57BL/6J [day 90] versus C57BL/6J [day 0] mice, or DBA/2J [day 90] versus DBA/2J [day 0] mice). A group of genes showing very high degrees of significance (changes of > or = 2.0-fold) displayed enrichment for transcripts associated with tissue remodeling and the fibrotic response. The differential expression of fibrotic response genes (Sparc, Col1a1, Col1a2, Col4a1, and Col4a2) in the infected lungs of the two mouse strains was validated by another microarray platform (Affymetrix oligonucleotide chips) and by reverse transcription-PCR. Furthermore, the differential expression of additional genes known to be associated with fibrosis (Mmp2, Timp1, and Arg1) was also validated by these approaches. Overall, these results identify the differential fibrotic response as a pathological basis for the high susceptibility of DBA/2J mice to pulmonary tuberculosis.

Entities:  

Mesh:

Year:  2007        PMID: 17938213      PMCID: PMC2223652          DOI: 10.1128/IAI.00369-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Inherited predisposition to mycobacterial infection: historical considerations.

Authors:  M Levin; M Newport
Journal:  Microbes Infect       Date:  2000-11       Impact factor: 2.700

Review 2.  Mycobacterium tuberculosis: here today, and here tomorrow.

Authors:  D G Russell
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

3.  Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.

Authors:  D K Madtes; A L Elston; L A Kaback; J G Clark
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

Review 4.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

5.  Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling.

Authors:  S Katsuma; K Nishi; K Tanigawara; H Ikawa; S Shiojima; K Takagaki; Y Kaminishi; Y Suzuki; A Hirasawa; T Ohgi; J Yano; Y Murakami; G Tsujimoto
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

6.  Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice.

Authors:  L M Mitsos; L R Cardon; A Fortin; L Ryan; R LaCourse; R J North; P Gros
Journal:  Genes Immun       Date:  2000-12       Impact factor: 2.676

7.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.

Authors:  D Cataldo; C Munaut; A Noël; F Frankenne; P Bartsch; J M Foidart; R Louis
Journal:  Int Arch Allergy Immunol       Date:  2000-11       Impact factor: 2.749

Review 9.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

Review 10.  Matrix metalloproteinases in lung biology.

Authors:  W C Parks; S D Shapiro
Journal:  Respir Res       Date:  2000-12-29
View more
  16 in total

1.  A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Authors:  Kerryn Matthews; Armin Deffur; Mpiko Ntsekhe; Faisal Syed; James B W Russell; Kemi Tibazarwa; Janine Wolske; Johan Brink; Bongani M Mayosi; Robert J Wilkinson; Katalin A Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

2.  Immunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients.

Authors:  S Danaviah; J A Sacks; K P S Kumar; L M Taylor; D A Fallows; T Naicker; T Ndung'u; S Govender; G Kaplan
Journal:  Tuberculosis (Edinb)       Date:  2013-03-28       Impact factor: 3.131

3.  The Saguenay-Lac-Saint-Jean asthma familial collection: the genetics of asthma in a young founder population.

Authors:  C Laprise
Journal:  Genes Immun       Date:  2014-03-20       Impact factor: 2.676

4.  Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.

Authors:  Jonathan M Pitt; Evangelos Stavropoulos; Paul S Redford; Amy M Beebe; Gregory J Bancroft; Douglas B Young; Anne O'Garra
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

5.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Authors:  Halli E Miller; Richard T Robinson
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

7.  Genetic and functional characterization of the mouse Trl3 locus in defense against tuberculosis.

Authors:  Jean-François Marquis; Ronald Lacourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

8.  Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4.

Authors:  Anne Fortier; Karine Doiron; Maya Saleh; Sergio Grinstein; Philippe Gros
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

Review 9.  Cell-mediated immune responses in tuberculosis.

Authors:  Andrea M Cooper
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.

Authors:  Mary A De Groote; Payam Nahid; Leah Jarlsberg; John L Johnson; Marc Weiner; Grace Muzanyi; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.